Commentary: improving the health of neglected populations in Latin America

Franco-Paredes, Carlos; Jones, Danielle; Rodríguez-Morales, Alfonso J.; Santos-Preciado, José Ignacio
January 2007
BMC Public Health;2007, Vol. 7, p11
Academic Journal
Neglected diseases encompass a group of pathologies that disproportionally affect resource-constrained areas of the world. In tropical and subtropical areas in Latin America, the vicious cycle of poverty, disease and underdevelopment is widespread. The burden of disease associated to neglected diseases in this region is mainly expressed through diseases such as malaria, dengue, intestinal parasitic infections, Chagas' disease, and many others. These maladies have burdened Latin America throughout centuries and have directly influenced their ability to develop and become competitive societies in the current climate of globalization. Therefore, the need for a new paradigm that integrates various public health policies, programs, and a strategy with the collaboration of all responsible sectors is long overdue. In this regard, innovative approaches are required to ensure the availability of low-cost, simple, sustainable, and locally acceptable strategies to improve the health of neglected populations to prevent, control, and potentially eliminate neglected diseases. Improving the health of these forgotten populations will place them in an environment more conducive to development and will likely contribute significantly to the achievement of the Millennium Development Goals in this area of the globe.


Related Articles

  • Chagas disease. Grayson, Michelle // Nature;6/24/2010 Supplement, Vol. 465 Issue 7301, pS3 

    An introduction to the journal is presented in which the editor discusses various articles on the understanding of Chagas disease and its treatment, the concerns about the disease's potential threat in the future, and the health challenges that requires basic and applied research investments.

  • Oxidative Stress in Chagas Disease. Gupta, Shivali; Jian-Jun Wen; Garg, Nisha Jain // Interdisciplinary Perspectives on Infectious Diseases;2009, p1 

    There is growing evidence to suggest that chagasic myocardia are exposed to sustained oxidative stress induced injuries that may contribute to disease progression. Trypanosoma cruzi invasion- and replication-mediated cellular injuries and immune-mediated cytotoxic reactions are the common source...

  • Specific Molecular Targets to Control Tropical Diseases. Rodriguez, Juan B. // Current Pharmaceutical Design;Aug2001, Vol. 7 Issue 12, p1105 

    Chagas disease or American trypanosomiasis is considered by the Word Health Organization to be one of the important tropical parasitic diseases worldwide together with malaria and schistosomiasis. The etiologic agent of this illness is the kinetoplastid protozoon Trypanosoma cruzi. The present...

  • Candidate Parasitic Diseases. Behbehani, K. // MMWR: Morbidity & Mortality Weekly Report;12/30/1999, Vol. 48, p80 

    This paper discusses five parasitic diseases: American trypanosomiasis (Chagas disease), dracunculiasis, lymphatic filariasis, onchocerciasis and schistosomiasis. The available technology and health infrastructures in developing countries permit the eradication of dracunculiasis and the...

  • Chromosomal imbalances are uncommon in chagasic megaesophagus. Bellini, Marilanda F.; Manzato, Antonio J.; Silva, Ana E.; Varella-Garcia, Marileila // BMC Gastroenterology;2010, Vol. 10, p20 

    Background: Chagas' disease is a human tropical parasitic illness and a subset of the chronic patients develop megaesophagus or megacolon. The esophagus dilation is known as chagasic megaesophagus (CM) and one of the severe late consequences of CM is the increased risk for esophageal carcinoma...

  • Mortality due to Chagas disease in Brazil from 1979 to 2009: trends and regional differences. Martins-Melo, Francisco Rogerlândio; Ramos Jr., Alberto Novaes; Alencar, Carlos Henrique; Heukelbach, Jorg // Journal of Infection in Developing Countries; 

    Introduction: Studies on mortality due to parasitic diseases such as Chagas disease are useful to understand the epidemiology and to plan and guide control measures for these diseases. We analyzed mortality trends due to Chagas disease in Brazil and regions, between 1979 and 2009. Methodology:...

  • Oral Transmission of Chagas Disease: New Epidemiology for an Old Disease. Blackburn, Brian G.; Barry, Michele // Travel Medicine Advisor;Jun2012, Vol. 22 Issue 6, p29 

    Synopsis: Several recent outbreaks of Chagas disease have been due to oral transmission. Although this protozoal infection is classically transmitted by triatomine insects, an emerging recognition of oral transmission could expand our understanding of the distribution for this parasitic infection

  • Encefalitis chagásica: una complicación tardía postrasplante cardiaco. De Castro Assis, Alfredo Fernández; Berdugo Sánchez, Alejandra; Cortés, Norma Lucía // Universitas Médica;ene-mar2008, Vol. 49 Issue 1, p112 

    Chagas' disease, also called American trypanosomiasis, is a human tropical parasitic disease that occurs in the Americas, particularly in South America. Its pathogenic agent is a flagellate protozoan named Trypanosoma cruzi, which very rarely involves the central nervous system. Few cases have...

  • New Therapeutic Targets for Drug Design Against Trypanosoma cruzi, Advances and Perspectives. Rivera, Gildardo; Bocanegra-García, Virgilio; Ordaz-Pichardo, Cynthia; Nogueda-Torres, Benjamin; Monge, Antonio // Current Medicinal Chemistry;Sep2009, Vol. 16 Issue 25, p3286 

    Chagas disease is one of the most important parasitic diseases in Latin America, affecting16 to 18 million people. Nifurtimox and Benznidazol are drugs that are commonly used in its treatment; however, these drugs produce several adverse reactions and are not effective in the chronic phase of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics